HPV-RELATED CARCINOMA
Clinical trials for HPV-RELATED CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new HPV-RELATED CARCINOMA trials appear
Sign up with your email to follow new studies for HPV-RELATED CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New weapon tested against Virus-Driven cancer
Disease control CompletedThis first-in-human study tested a new drug called CUE-101, designed to activate the immune system to fight cancers caused by HPV. It was given to about 80 adults with advanced head and neck cancer, either alone for patients who had already tried other treatments, or combined wit…
Matched conditions: HPV-RELATED CARCINOMA
Phase: PHASE1 • Sponsor: Cue Biopharma • Aim: Disease control
Last updated Apr 02, 2026 02:40 UTC
-
Scientists track HPV vaccine protection in High-Risk women
Knowledge-focused CompletedThis study examines how well the HPV vaccine protects against infections that can lead to cervical cancer over many years. Researchers followed 3,127 Rwandan women aged 18-28, including those living with and without HIV, to compare infection rates between vaccinated and unvaccina…
Matched conditions: HPV-RELATED CARCINOMA
Sponsor: Montefiore Medical Center • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:43 UTC